Sep 30, 2015

ANI Pharmaceuticals Q3 2015 Earnings Report

Total Revenue
$20M
Previous year: $17.4M
+14.8%
EPS
$0.8
Previous year: $0.66
+21.2%
Gross Profit
$16.7M
Previous year: $14.3M
+16.7%
Cash and Equivalents
$151M
Previous year: $35.1M
+330.6%
Free Cash Flow
$9.47M
Previous year: $3.75M
+152.6%
Total Assets
$283M
Previous year: $108M
+163.2%

ANI Pharmaceuticals

ANI Pharmaceuticals